Merck & Co. Inc. buy Barclays PLC
Start price
02.02.24
/
50%
€116.60
Target price
02.02.25
€134.11
Performance (%)
3.52%
Price
12:57
€120.00
Summary
This prediction is currently active. With a performance of 3.52%, the BUY prediction by Barclays_PLC for Merck & Co. Inc. is trending in the right direction. Dividends of €0.71 are taken into consideration when calculating the performance. This prediction currently runs until 02.02.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Merck & Co. Inc. | 1.852% | 1.852% |
iShares Core DAX® | -0.992% | -3.231% |
iShares Nasdaq 100 | -0.225% | -3.339% |
iShares Nikkei 225® | -0.736% | -7.859% |
iShares S&P 500 | -0.509% | -2.979% |
Comments by Barclays_PLC for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target raised by analysts at Barclays PLC from $135.00 to $145.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat